How to buy Seer (SEER) stock

Seer, Inc is a biotechnology business based in the US. Seer shares (SEER) are listed on the NASDAQ and all prices are listed in US Dollars. Seer employs 60 staff and has a trailing 12-month revenue of around 0.00.

Seer stock price (NASDAQ: SEER)

Use our graph to track the performance of SEER stocks over time.

Seer shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$29.58
52-week range	$26.48 - $86.55
50-day moving average	$32.16
200-day moving average	$47.02
Wall St. target price	$59.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Seer shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Seer stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Seer, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Seer price performance over time

Historical closes compared with the close of $29.58 from 2021-05-28

1 week (2021-07-17)	N/A
1 month (2021-06-28)	-14.26%
3 months (2021-04-28)	-43.83%
6 months (2021-01-24)	N/A

1 year (2020-07-24)	N/A
2 years (2019-07-24)	N/A
3 years (2018-07-24)	N/A
5 years (2016-07-24)	N/A

Seer financials

Revenue TTM	$541,000
Gross profit TTM	$-18,286,000
Return on assets TTM	-7.85%
Return on equity TTM	-12.62%
Profit margin	0%
Book value	$8.74
Market capitalisation	$2.1 billion

TTM: trailing 12 months

Shorting Seer shares

There are currently 4.2 million Seer shares held short by investors – that's known as Seer's "short interest". This figure is 7.3% down from 4.5 million last month.

There are a few different ways that this level of interest in shorting Seer shares can be evaluated.

Seer's "short interest ratio" (SIR)

Seer's "short interest ratio" (SIR) is the quantity of Seer shares currently shorted divided by the average quantity of Seer shares traded daily (recently around 509734.55882353). Seer's SIR currently stands at 8.16. In other words for every 100,000 Seer shares traded daily on the market, roughly 8160 shares are currently held short.

To gain some more context, you can compare Seer's short interest ratio against those of similar companies.

• Chembio Diagnostics (CEMI.US): 2.26
• Bicycle Therapeutics (BCYC.US): 7.66
• Selecta Biosciences (SELB.US): 5.67

However Seer's short interest can also be evaluated against the total number of Seer shares, or, against the total number of tradable Seer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Seer's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Seer shares in existence, roughly 70 shares are currently held short) or 0.1333% of the tradable shares (for every 100,000 tradable Seer shares, roughly 133 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Seer.

Find out more about how you can short Seer stock.

Seer share dividends

We're not expecting Seer to pay a dividend over the next 12 months.

Seer overview

Seer, Inc. , a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc.

Frequently asked questions

What percentage of Seer is owned by insiders or institutions?
Currently 13.434% of Seer shares are held by insiders and 79.116% by institutions. How many people work for Seer?
Latest data suggests 60 work at Seer. When does the fiscal year end for Seer?
Seer's fiscal year ends in December. Where is Seer based?
Seer's address is: 3800 Bridge Parkway, Redwood City, CA, United States, 94065